0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

JAMA Neurology | 
Original Investigation |  ONLINE FIRST
Olga Marshall, MS; Hanzhang Lu, PhD; Jean-Christophe Brisset, PhD; et al.
JAMA Neurol. Published online August 18, 2014. doi:10.1001/jamaneurol.2014.1668

JAMA Neurology | 
Original Investigation | 
Marinella Clerico, MD; Irene Schiavetti, BS; Stefania F. De Mercanti, MD; et al.
JAMA Neurol. 2014;71(8):954-960. doi:10.1001/jamaneurol.2014.1200.

JAMA Neurology | 
Editorial | 
Olaf Stüve, MD, PhD; Gary R. Cutter, PhD
JAMA Neurol. 2014;71(8):945-946. doi:10.1001/jamaneurol.2014.1201.

JAMA Dermatology | 
Research Letter | 
Momen Pharaon, MD; Mélanie Tichet, MSc; Christine Lebrun-Frénay, MD, PhD; et al.
JAMA Dermatol. 2014;150(8):901-903. doi:10.1001/jamadermatol.2013.9411.
Includes: Supplemental Content

JAMA Neurology | 
Viewpoint | 
Jagannadha Avasarala, MD, PhD
JAMA Neurol. 2014;71(8):943-944. doi:10.1001/jamaneurol.2014.79.

JAMA Neurology | 
Case Report/Case Series | 
Yong Guo, MD, PhD; Vanda A. Lennon, MD, PhD; Bogdan F. Gh. Popescu, MD, PhD; et al.
JAMA Neurol. 2014;71(8):1025-1029. doi:10.1001/jamaneurol.2014.775.

JAMA Ophthalmology | 
JAMA Ophthalmology Clinical Challenge | 
Neda Nikpoor, MD; Ninel Gregori, MD; Jonathan S. Chang, MD
JAMA Ophthalmol. 2014;132(7):885-886. doi:10.1001/jamaophthalmol.2014.1407.

JAMA Neurology | 
Original Investigation | 
Sara Llufriu, MD, PhD; John Kornak, PhD; Helene Ratiney, PhD; et al.
JAMA Neurol. 2014;71(7):840-847. doi:10.1001/jamaneurol.2014.895.
Includes: Supplemental Content

JAMA Neurology | 
Editorial | 
David H. Miller, MD
JAMA Neurol. 2014;71(7):828-830. doi:10.1001/jamaneurol.2014.896.

JAMA Neurology | 
Review | 
Sascha Alvermann, MD; Christian Hennig, MD; Olaf Stüve, MD, PhD; et al.
JAMA Neurol. 2014;71(7):905-912. doi:10.1001/jamaneurol.2014.395.
Includes: Supplemental Content

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA Neurology
Original Investigation  | 
Impaired Cerebrovascular Reactivity in Multiple Sclerosis
Olga Marshall, MS; Hanzhang Lu, PhD; Jean-Christophe Brisset, PhD; et al.
JAMA Dermatology
Research Letter  | 
Risk for Nevus Transformation and Melanoma Proliferation and Invasion During Natalizumab Treatment:  Four Years of Dermoscopic Follow-up With Immunohistological Studies and Proliferation and Invasion Assays
Momen Pharaon, MD; Mélanie Tichet, MSc; Christine Lebrun-Frénay, MD, PhD; et al.
JAMA Neurology
Case Report/Case Series  | 
Autoimmune Aquaporin-4 Myopathy in Neuromyelitis Optica Spectrum
Yong Guo, MD, PhD; Vanda A. Lennon, MD, PhD; Bogdan F. Gh. Popescu, MD, PhD; et al.
JAMA Neurology
Viewpoint  | 
Inadequacy of Clinical Trial Designs and Data to Control for the Confounding Impact of Race/Ethnicity in Response to Treatment in Multiple Sclerosis
Jagannadha Avasarala, MD, PhD